What is the ASP rate for nonpass-through drugs in 2020?
According to the Centers for Medicare & Medicaid Services (CMS), for 2020, payment for nonpass-through drugs that were not acquired through the 340B Program will be made at a single rate of ASP + 6 percent (or ASP + 6 percent of the reference product for biosimilars).
CPT© copyright 2020 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.